NeuroOne Medical Technologies logo

NeuroOne Medical TechnologiesNASDAQ: NMTC

Profile

Sector:

Healthcare

Country:

United States

IPO:

15 March 2018

Next earnings report:

30 August 2024

Last dividends:

N/A

Next dividends:

N/A
$22.57 M
-72%vs. 3y high
25%vs. sector
-vs. 3y high
-vs. sector
-45%vs. 3y high
87%vs. sector
-99%vs. 3y high
66%vs. sector

Price

regular market | 3 min ago
$0.82-$0.05(-5.39%)

Dividend

No data over the past 3 years
$1.38 M$2.00 M
$1.38 M-$2.86 M

Analysts recommendations

Institutional Ownership

NMTC Latest News

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript
Seeking Alpha14 May 2024 Sentiment: NEUTRAL

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) will hold its Q2 2024 Earnings Conference Call on May 14, 2024 at 4:30 PM ET. Presenting will be Dave Rosa, President & CEO, and Ron McClurg, CFO. Welcome to the NeuroOne Medical Technologies Corporation Second Quarter of Fiscal Year 2024 Financial Results Conference Call.

NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript
Seeking Alpha13 February 2024 Sentiment: NEUTRAL

NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
GlobeNewsWire08 February 2024 Sentiment: POSITIVE

EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on February 13, 2024 at 4:30 PM Eastern Time to discuss financial results for its first quarter of fiscal year 2024 ended December 31, 2023, and provide a corporate update.

NeuroOne Medical Technologies Corporation (NMTC) Q3 2023 Earnings Call Transcript
Seeking Alpha14 August 2023 Sentiment: POSITIVE

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Operator Good day, ladies and gentlemen. Thank you for standing by.

NeuroOne Medical Technologies Corporation (NMTC) Q2 2023 Earnings Call Transcript
Seeking Alpha12 May 2023 Sentiment: POSITIVE

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. And welcome to the NeuroOne Medical Technologies Corporation Second Quarter Fiscal Year 2023 Financial Results Conference Call.

NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11
GlobeNewsWire11 May 2023 Sentiment: POSITIVE

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal second quarter 2023 ended March 31, 2023 and provide a corporate update on May 11, 2023 at 4:30 PM Eastern Time.

What type of business is NeuroOne Medical Technologies?

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

What sector is NeuroOne Medical Technologies in?

NeuroOne Medical Technologies is in the Healthcare sector

What industry is NeuroOne Medical Technologies in?

NeuroOne Medical Technologies is in the Medical Devices industry

What country is NeuroOne Medical Technologies from?

NeuroOne Medical Technologies is headquartered in United States

When did NeuroOne Medical Technologies go public?

NeuroOne Medical Technologies initial public offering (IPO) was on 15 March 2018

What is NeuroOne Medical Technologies website?

https://n1mtc.com

Is NeuroOne Medical Technologies in the S&P 500?

No, NeuroOne Medical Technologies is not included in the S&P 500 index

Is NeuroOne Medical Technologies in the NASDAQ 100?

No, NeuroOne Medical Technologies is not included in the NASDAQ 100 index

Is NeuroOne Medical Technologies in the Dow Jones?

No, NeuroOne Medical Technologies is not included in the Dow Jones index

When does NeuroOne Medical Technologies report earnings?

The next expected earnings date for NeuroOne Medical Technologies is 30 August 2024